Insights & Research
SERVICES
We have ore than 50 years of experience
Tilt phone to view map
Blinking indicates recent activity
-States that are not clickable have no meaningful activity.

DC
District of Columbia Snapshot
Notable Players

Population
~0.7MM
Medicinal Legalization
1998
First Adult-Use Sale
Pending
MMJ Patients
29K
Monthly Revenue
~$1.6MM
Cultivation Licenses (Operational/Limit)
6/10 (Operational/Limit)
Retail Licenses (Operational/Limit)
20/20 (Operational/Limit)
Updated on Mar 24, 2025
ME
Maine Snapshot
Notable Players



Population
~1.4MM
Medicinal Legalization
1999
First Adult-Use Sale
2020
MMJ Patients
~6K
Monthly Revenue
~$20.3MM
Cultivation Licenses (Operational/Limit)
123/No Limit (Operational/Limit)
Retail Licenses (Operational/Limit)
321/No Limit (Operational/Limit)
Updated on Mar 24, 2025
VT
Vermont Snapshot
Notable Players

Population
~0.65MM
Medicinal Legalization
2004
First Adult-Use Sale
2022
MMJ Patients
~3K
Monthly Revenue
~$11.9MM
Cultivation Licenses (Operational/Limit)
396/No Limit (Operational/Limit)*
Retail Licenses (Operational/Limit)
109/No Limit (Operational/Limit)*
Updated on Mar 24, 2025
NH
New Hampshire Snapshot
Notable Players

Population
~1.4MM
Medicinal Legalization
2013
First Adult-Use Sale
N/A
MMJ Patients
~14K
Monthly Revenue
~$3.5MM
Cultivation Licenses (Operational/Limit)
4/4 (Operational/Limit)*
Retail Licenses (Operational/Limit)
7/7 (Operational/Limit)*
Updated on Mar 24, 2025
MA
Massachusetts Snapshot
Notable Players




Population
~7.1MM
Medicinal Legalization
2012
First Adult-Use Sale
2018
MMJ Patients
~84K
Monthly Revenue
~$154.7MM
Cultivation Licenses (Operational/Limit)
332/No Limit (Operational/Limit)
Retail Licenses (Operational/Limit)
498/No Limit (Operational/Limit)
Updated on Mar 24, 2025
RI
Rhode Island Snapshot
Notable Players


Population
~1.1MM
Medicinal Legalization
2005
First Adult-Use Sale
2022
MMJ Patients
~11K
Monthly Revenue
~$10.0MM
Cultivation Licenses (Operational/Limit)
60/No Limit (Operational/Limit)
Retail Licenses (Operational/Limit)
7/33 (Operational/Limit)
Updated on Mar 24, 2025
CT
Connecticut Snapshot
Notable Players




Population
~3.7MM
Medicinal Legalization
2012
First Adult-Use Sale
2023
MMJ Patients
~35K
Monthly Revenue
~$25.4MM
Cultivation Licenses (Operational/Limit)
14/21 (Operational/Limit)
Retail Licenses (Operational/Limit)
61/No Limit (Operational/Limit)
Updated on Mar 24, 2025
NY
New York Snapshot
Notable Players




Population
~19.9MM
Medicinal Legalization
2014
First Adult-Use Sale
2022
MMJ Patients
~98K
Monthly Revenue
~$100.0MM
Cultivation Licenses (Operational/Limit)
280/No Limit (Operational/Limit)*
Retail Licenses (Operational/Limit)
330/No Limit (Operational/Limit)*
Updated on Mar 24, 2025
NJ
New Jersey Snapshot
Notable Players



Population
~9.5MM
Medicinal Legalization
2010
First Adult-Use Sale
2022
MMJ Patients
~65K
Monthly Revenue
~$92.5MM
Cultivation Licenses (Operational/Limit)
63/No Limit (Operational/Limit)*
Retail Licenses (Operational/Limit)
205/No Limit (Operational/Limit)*
Updated on Mar 24, 2025
DE
Delaware Snapshot
Notable Players

Population
~1.0MM
Medicinal Legalization
2011
First Adult-Use Sale
Pending
MMJ Patients
~28K
Monthly Revenue
~$5.2MM
Cultivation Licenses (Operational/Limit)
60/No Limit (Operational/Limit)
Retail Licenses (Operational/Limit)
30/No Limit (Operational/Limit)
Updated on Mar 24, 2025
MD
Maryland Snapshot
Notable Players




Population
~6.3MM
Medicinal Legalization
2014
First Adult-Use Sale
2023
MMJ Patients
~102K
Monthly Revenue
~$97.0MM
Cultivation Licenses (Operational/Limit)
20/75 (Operational/Limit)
Retail Licenses (Operational/Limit)
101/300* (Operational/Limit)
Updated on Mar 24, 2025
PA
Pennsylvania Snapshot
Notable Players




Population
~13.0MM
Medicinal Legalization
2016
First Adult-Use Sale
N/A
MMJ Patients
~441K
Monthly Revenue
~$140.0MM
Cultivation Licenses (Operational/Limit)
33/33 (Operational/Limit)
Retail Licenses (Operational/Limit)
181/No Limit (Operational/Limit)*
Updated on Jun 12, 2024
VA
Virginia Snapshot
Notable Players


Population
~8.8MM
Medicinal Legalization
2018
First Adult-Use Sale
N/A
MMJ Patients
~100K
Monthly Revenue
~$5.5MM
Cultivation Licenses (Operational/Limit)
4/5 (Operational/Limit)*
Retail Licenses (Operational/Limit)
23/30 (Operational/Limit)*
Updated on Mar 25, 2025
NC
North Carolina Snapshot
Notable Players
Population
~11.0MM
Medicinal Legalization
N/A
First Adult-Use Sale
N/A
MMJ Patients
N/A
Monthly Revenue
N/A
Cultivation Licenses (Operational/Limit)
N/A
Retail Licenses (Operational/Limit)
N/A
Updated on Mar 25, 2025
SC
South Carolina Snapshot
Notable Players
Population
~5.5MM
Medicinal Legalization
N/A
First Adult-Use Sale
N/A
MMJ Patients
N/A
Monthly Revenue
N/A
Cultivation Licenses (Operational/Limit)
N/A
Retail Licenses (Operational/Limit)
N/A
Updated on Mar 25, 2025
FL
Florida Snapshot
Notable Players



Population
~23.4MM
Medicinal Legalization
2014
First Adult-Use Sale
N/A
MMJ Patients
~899K
Monthly Revenue
~$145.5MM
Cultivation Licenses (Operational/Limit)
25/27 (Operational/Limit)*
Retail Licenses (Operational/Limit)
703/No Limit (Operational/Limit)*
Updated on Mar 25, 2025
GA
Georgia Snapshot
Notable Players

Population
~11.2MM
Medicinal Legalization
2015
First Adult-Use Sale
N/A
MMJ Patients
~25K
Monthly Revenue
0
Cultivation Licenses (Operational/Limit)
6/6 (Operational/Limit)
Retail Licenses (Operational/Limit)
14/42* (Operational/Limit)
Updated on Mar 24, 2025
MS
Mississippi Snapshot
Notable Players
Population
~2.9MM
Medicinal Legalization
2022
First Adult-Use Sale
N/A
MMJ Patients
51k
Monthly Revenue
~$9.2MM
Cultivation Licenses (Operational/Limit)
122/No Limit (Operational/Limit)
Retail Licenses (Operational/Limit)
200/No Limit (Operational/Limit)
Updated on Mar 25, 2025
AL
Alabama Snapshot
Notable Players
Population
~5.2MM
Medicinal Legalization
2021
First Adult-Use Sale
N/A
MMJ Patients
N/A
Monthly Revenue
N/A
Cultivation Licenses (Operational/Limit)
0/5 (Operational/Limit)
Retail Licenses (Operational/Limit)
0/5 (Operational/Limit)
Updated on Mar 25, 2025
KY
Kentucky Snapshot
Notable Players
Population
~4.6MM
Medicinal Legalization
2023
First Adult-Use Sale
N/A
MMJ Patients
N/A
Monthly Revenue
N/A
Cultivation Licenses (Operational/Limit)
16/16 (Operational/Limit)*
Retail Licenses (Operational/Limit)
48/48 (Operational/Limit)*
Updated on Mar 26, 2025
OH
Ohio Snapshot
Notable Players




Population
~11.8MM
Medicinal Legalization
2016
First Adult-Use Sale
N/A
MMJ Patients
~428K
Monthly Revenue
~$37.1MM
Cultivation Licenses (Operational/Limit)
34/37 (Operational/Limit)
Retail Licenses (Operational/Limit)
124/132 (Operational/Limit)
Updated on Jun 14, 2024
MI
Michigan Snapshot
Notable Players




Population
~10.1MM
Medicinal Legalization
2008
First Adult-Use Sale
2019
MMJ Patients
~79K
Monthly Revenue
~$276.3MM
Cultivation Licenses (Operational/Limit)
1,813/No Limit (Operational/Limit)
Retail Licenses (Operational/Limit)
848/ No Limit (Operational/Limit)
Updated on Mar 24, 2025
IL
Illinois Snapshot
Notable Players




Population
~12.7MM
Medicinal Legalization
2013
First Adult-Use Sale
2020
MMJ Patients
~138K
Monthly Revenue
~$172.8MM
Cultivation Licenses (Operational/Limit)
109/180* (Operational/Limit)
Retail Licenses (Operational/Limit)
241/500* (Operational/Limit)
Updated on Mar 25, 2025
WI
Wisconsin Snapshot
Notable Players
Population
~6.0MM
Medicinal Legalization
N/A
First Adult-Use Sale
N/A
MMJ Patients
N/A
Monthly Revenue
N/A
Cultivation Licenses (Operational/Limit)
N/A
Retail Licenses (Operational/Limit)
N/A
Updated on Mar 25, 2025
LA
Louisiana Snapshot
Notable Players
Population
~4.6MM
Medicinal Legalization
2016
First Adult-Use Sale
N/A
MMJ Patients
~53K
Monthly Revenue
~$2.3MM
Cultivation Licenses (Operational/Limit)
2/2 (Operational/Limit)
Retail Licenses (Operational/Limit)
22/30 (Operational/ Limit)
Updated on Mar 25, 2025
AR
Arkansas Snapshot
Notable Players


Population
~3.1MM
Medicinal Legalization
2016
First Adult-Use Sale
N/A
MMJ Patients
~109K
Monthly Revenue
~$24MM
Cultivation Licenses (Operational/Limit)
16/16 (Operational/Limit)
Retail Licenses (Operational/Limit)
38/40 (Operational/Limit)
Updated on Mar 24, 2025
MO
Missouri Snapshot
Notable Players




Population
~6.2MM
Medicinal Legalization
2018
First Adult-Use Sale
2023
MMJ Patients
~119K
Monthly Revenue
~$130.9MM
Cultivation Licenses (Operational/Limit)
66/66 (Operational/Limit)
Retail Licenses (Operational/Limit)
224/No Limit* (Operational/Limit)
Updated on Mar 25, 2025
IA
Iowa Snapshot
Notable Players
Population
~3.2MM
Medicinal Legalization
2017
First Adult-Use Sale
N/A
MMJ Patients
~18K
Monthly Revenue
~$1.1MM
Cultivation Licenses (Operational/Limit)
2/2 (Operational/Limit)
Retail Licenses (Operational/Limit)
5/5 (Operational/Limit)
Updated on Mar 24, 2025
MN
Minnesota Snapshot
Notable Players


Population
~5.8MM
Medicinal Legalization
2014
First Adult-Use Sale
2023
MMJ Patients
~51K
Monthly Revenue
~$9.2MM
Cultivation Licenses (Operational/Limit)
6/31 (Operational/Limit)*
Retail Licenses (Operational/Limit)
15/90 (Operational/Limit)*
Updated on Mar 24, 2025
HI
Hawaii Snapshot
Notable Players
Population
~1.4MM
Medicinal Legalization
2000
First Adult-Use Sale
N/A
MMJ Patients
~33K
Monthly Revenue
~$4.3MM
Cultivation Licenses (Operational/Limit)
8/8 (Operational/Limit)*
Retail Licenses (Operational/Limit)
23/No Limit (Operational/Limit)*
Updated on Oct 23, 2023
AK
Alaska Snapshot
Notable Players
Population
~0.7MM
Medicinal Legalization
1998
First Adult-Use Sale
2016
MMJ Patients
~0k
Monthly Revenue
~$10.0MM
Cultivation Licenses (Operational/Limit)
234/No Limit (Operational/Limit)
Retail Licenses (Operational/Limit)
199/No Limit (Operational/Limit)
Updated on Mar 24, 2025
ND
North Dakota Snapshot
Notable Players


Population
~0.8MM
Medicinal Legalization
2016
First Adult-Use Sale
N/A
MMJ Patients
~10K
Monthly Revenue
~$1.9MM
Cultivation Licenses (Operational/Limit)
2/2 (Operational/Limit)
Retail Licenses (Operational/Limit)
8/8 (Operational/Limit)
Updated on Mar 25, 2025
SD
South Dakota Snapshot
Notable Players
Population
~0.9MM
Medicinal Legalization
2020
First Adult-Use Sale
N/A
MMJ Patients
~11k
Monthly Revenue
Not Reported
Cultivation Licenses (Operational/Limit)
34/No Limit (Operational/ Limit)
Retail Licenses (Operational/Limit)
65/No Limit (Operational/ Limit)
Updated on Mar 24, 2025
KS
Kansas Snapshot
Notable Players
Population
~3.0MM
Medicinal Legalization
N/A
First Adult-Use Sale
N/A
MMJ Patients
N/A
Monthly Revenue
N/A
Cultivation Licenses (Operational/Limit)
N/A
Retail Licenses (Operational/Limit)
N/A
Updated on Mar 24, 2025
OK
Oklahoma Snapshot
Notable Players
Population
~4.1MM
Medicinal Legalization
2018
First Adult-Use Sale
N/A
MMJ Patients
~340K
Monthly Revenue
~$60.0MM
Cultivation Licenses (Operational/Limit)
2,939/No Limit (Operational/Limit)
Retail Licenses (Operational/Limit)
1,747/No Limit (Operational/Limit)
Updated on Mar 25, 2025
TX
Texas Snapshot
Notable Players


Population
~31.3MM
Medicinal Legalization
2015
First Adult-Use Sale
N/A
MMJ Patients
~103K
Monthly Revenue
Negligible
Cultivation Licenses (Operational/Limit)
3/3 (Operational/Limit)
Retail Licenses (Operational/Limit)
3/3 (Operational/Limit)
Updated on Mar 25, 2025
NM
New Mexico Snapshot
Notable Players



Population
~2.1MM
Medicinal Legalization
2007
First Adult-Use Sale
2022
MMJ Patients
~79K
Monthly Revenue
~$48.7MM
Cultivation Licenses (Operational/Limit)
1,075/No Limit (Operational/Limit)*
Retail Licenses (Operational/Limit)
1,006/No Limit (Operational/Limit)*
Updated on Mar 24, 2025
CO
Colorado Snapshot
Notable Players




Population
~5.8MM
Medicinal Legalization
2000
First Adult-Use Sale
2014
MMJ Patients
~69K
Monthly Revenue
~$110.3MM
Cultivation Licenses (Operational/Limit)
722/No Limit (Operational/Limit)
Retail Licenses (Operational/Limit)
1,023/No Limit (Operational/Limit)
Updated on Jun 13, 2024
WY
Wyoming Snapshot
Notable Players
Population
~0.6MM
Medicinal Legalization
N/A
First Adult-Use Sale
N/A
MMJ Patients
N/A
Monthly Revenue
N/A
Cultivation Licenses (Operational/Limit)
N/A
Retail Licenses (Operational/Limit)
N/A
Updated on Mar 24, 2025
MT
Montana Snapshot
Notable Players
Population
~1.1MM
Medicinal Legalization
2004
First Adult-Use Sale
2022
MMJ Patients
No Available Data
Monthly Revenue
~$26.0MM
Cultivation Licenses (Operational/Limit)
330/No Limit (Operational/Limit)
Retail Licenses (Operational/Limit)
468/No Limit (Operational/Limit)
Updated on Mar 24, 2025
NV
Nevada Snapshot
Notable Players




Population
~3.3MM
Medicinal Legalization
2000
First Adult-Use Sale
2017
MMJ Patients
~10.6K
Monthly Revenue
~$70.7MM
Cultivation Licenses (Operational/Limit)
129/No Limit (Operational/Limit)
Retail Licenses (Operational/Limit)
103/166(Operational/Limit)
Updated on Mar 24, 2025
UT
Utah Snapshot
Notable Players


Population
~3.4MM
Medicinal Legalization
2018
First Adult-Use Sale
N/A
MMJ Patients
~69K
Monthly Revenue
~$12.1MM
Cultivation Licenses (Operational/Limit)
8/10 (Operational/Limit)
Retail Licenses (Operational/Limit)
15/15 (Operational/Limit)
Updated on Oct 23, 2023
AZ
Arizona Snapshot
Notable Players




Population
~7.4MM
Medicinal Legalization
2010
First Adult-Use Sale
2021
MMJ Patients
~128K
Monthly Revenue
~$105.2MM
Cultivation Licenses (Operational/Limit)
250/250 (Operational/Limit)
Retail Licenses (Operational/Limit)
250/250 (Operational/Limit)
Updated on Oct 23, 2023
CA
California Snapshot
Notable Players




Population
~39.0MM
Medicinal Legalization
1996
First Adult-Use Sale
2018
MMJ Patients
~467K
Monthly Revenue
~$359.2.1MM
Cultivation Licenses (Operational/Limit)
5,735/No Limit (Operational/Limit)
Retail Licenses (Operational/Limit)
2,387/No Limit (Operational/Limit)
Updated on Oct 23, 2023
OR
Oregon Snapshot
Notable Players


Population
~4.2MM
Medicinal Legalization
1998
First Adult-Use Sale
2015
MMJ Patients
~17K
Monthly Revenue
~$80.1MM
Cultivation Licenses (Operational/Limit)
1,424/No Limit (Operational/Limit)
Retail Licenses (Operational/Limit)
946/No Limit (Operational/Limit)
Updated on Oct 23, 2023
WA
Washington Snapshot
Notable Players

Population
~7.8MM
Medicinal Legalization
1998
First Adult-Use Sale
2014
MMJ Patients
~104K
Monthly Revenue
~$117.4MM
Cultivation Licenses (Operational/Limit)
1,012/No Limit (Operational/Limit)
Retail Licenses (Operational/Limit)
704/No Limit (Operational/Limit)
Updated on Oct 23, 2023
WA
Market Research
Top MSO's
Year Passed
1999
Year Passed
1999
Year Passed
1999
Year Passed
1999
Year Passed
1999
Year Passed
1999
Updated on 10/20/20
Adult & Medical Use
Legal Medical Use
Medical Use - CBD Only
Prohibited
Blinking indicates recent activity
-States that are not clickable have no meaningful activity.

DC
District of Columbia Market Research
Notable Players

Population
~0.7MM
Medicinal Legalization
1998
First Adult-Use Sale
Pending
MMJ Patients
29K
Monthly Revenue
~$1.6MM
Cultivation Licenses
6/10 (Operational/Limit)
Retail Licenses
20/20 (Operational/Limit)
Updated on Mar 24, 2025
ME
Maine Market Research
Notable Players



Population
~1.4MM
Medicinal Legalization
1999
First Adult-Use Sale
2020
MMJ Patients
~6K
Monthly Revenue
~$20.3MM
Cultivation Licenses
123/No Limit (Operational/Limit)
Retail Licenses
321/No Limit (Operational/Limit)
Updated on Mar 24, 2025
VT
Vermont Market Research
Notable Players

Population
~0.65MM
Medicinal Legalization
2004
First Adult-Use Sale
2022
MMJ Patients
~3K
Monthly Revenue
~$11.9MM
Cultivation Licenses
396/No Limit (Operational/Limit)*
Retail Licenses
109/No Limit (Operational/Limit)*
Updated on Mar 24, 2025
MA
Massachusetts Market Research
Notable Players




Population
~7.1MM
Medicinal Legalization
2012
First Adult-Use Sale
2018
MMJ Patients
~84K
Monthly Revenue
~$154.7MM
Cultivation Licenses
332/No Limit (Operational/Limit)
Retail Licenses
498/No Limit (Operational/Limit)
Updated on Mar 24, 2025
RI
Rhode Island Market Research
Notable Players


Population
~1.1MM
Medicinal Legalization
2005
First Adult-Use Sale
2022
MMJ Patients
~11K
Monthly Revenue
~$10.0MM
Cultivation Licenses
60/No Limit (Operational/Limit)
Retail Licenses
7/33 (Operational/Limit)
Updated on Mar 24, 2025
CT
Connecticut Market Research
Notable Players




Population
~3.7MM
Medicinal Legalization
2012
First Adult-Use Sale
2023
MMJ Patients
~35K
Monthly Revenue
~$25.4MM
Cultivation Licenses
14/21 (Operational/Limit)
Retail Licenses
61/No Limit (Operational/Limit)
Updated on Mar 24, 2025
NY
New York Market Research
Notable Players




Population
~19.9MM
Medicinal Legalization
2014
First Adult-Use Sale
2022
MMJ Patients
~98K
Monthly Revenue
~$100.0MM
Cultivation Licenses
280/No Limit (Operational/Limit)*
Retail Licenses
330/No Limit (Operational/Limit)*
Updated on Mar 24, 2025
NJ
New Jersey Market Research
Notable Players



Population
~9.5MM
Medicinal Legalization
2010
First Adult-Use Sale
2022
MMJ Patients
~65K
Monthly Revenue
~$92.5MM
Cultivation Licenses
63/No Limit (Operational/Limit)*
Retail Licenses
205/No Limit (Operational/Limit)*
Updated on Mar 24, 2025
DE
Delaware Market Research
Notable Players

Population
~1.0MM
Medicinal Legalization
2011
First Adult-Use Sale
Pending
MMJ Patients
~28K
Monthly Revenue
~$5.2MM
Cultivation Licenses
60/No Limit (Operational/Limit)
Retail Licenses
30/No Limit (Operational/Limit)
Updated on Mar 24, 2025
MD
Maryland Market Research
Notable Players




Population
~6.3MM
Medicinal Legalization
2014
First Adult-Use Sale
2023
MMJ Patients
~102K
Monthly Revenue
~$97.0MM
Cultivation Licenses
20/75 (Operational/Limit)
Retail Licenses
101/300* (Operational/Limit)
Updated on Mar 24, 2025
VA
Virginia Market Research
Notable Players


Population
~8.8MM
Medicinal Legalization
2018
First Adult-Use Sale
N/A
MMJ Patients
~100K
Monthly Revenue
~$5.5MM
Cultivation Licenses
4/5 (Operational/Limit)*
Retail Licenses
23/30 (Operational/Limit)*
Updated on Mar 25, 2025
OH
Ohio Market Research
Notable Players




Population
~11.8MM
Medicinal Legalization
2016
First Adult-Use Sale
N/A
MMJ Patients
~428K
Monthly Revenue
~$37.1MM
Cultivation Licenses
34/37 (Operational/Limit)
Retail Licenses
124/132 (Operational/Limit)
Updated on Jun 14, 2024
MI
Michigan Market Research
Notable Players




Population
~10.1MM
Medicinal Legalization
2008
First Adult-Use Sale
2019
MMJ Patients
~79K
Monthly Revenue
~$276.3MM
Cultivation Licenses
1,813/No Limit (Operational/Limit)
Retail Licenses
848/ No Limit (Operational/Limit)
Updated on Mar 24, 2025
IL
Illinois Market Research
Notable Players




Population
~12.7MM
Medicinal Legalization
2013
First Adult-Use Sale
2020
MMJ Patients
~138K
Monthly Revenue
~$172.8MM
Cultivation Licenses
109/180* (Operational/Limit)
Retail Licenses
241/500* (Operational/Limit)
Updated on Mar 25, 2025
MO
Missouri Market Research
Notable Players




Population
~6.2MM
Medicinal Legalization
2018
First Adult-Use Sale
2023
MMJ Patients
~119K
Monthly Revenue
~$130.9MM
Cultivation Licenses
66/66 (Operational/Limit)
Retail Licenses
224/No Limit* (Operational/Limit)
Updated on Mar 25, 2025
MN
Minnesota Market Research
Notable Players


Population
~5.8MM
Medicinal Legalization
2014
First Adult-Use Sale
2023
MMJ Patients
~51K
Monthly Revenue
~$9.2MM
Cultivation Licenses
6/31 (Operational/Limit)*
Retail Licenses
15/90 (Operational/Limit)*
Updated on Mar 24, 2025
AK
Alaska Market Research
Notable Players
Population
~0.7MM
Medicinal Legalization
1998
First Adult-Use Sale
2016
MMJ Patients
~0k
Monthly Revenue
~$10.0MM
Cultivation Licenses
234/No Limit (Operational/Limit)
Retail Licenses
199/No Limit (Operational/Limit)
Updated on Mar 24, 2025
NM
New Mexico Market Research
Notable Players



Population
~2.1MM
Medicinal Legalization
2007
First Adult-Use Sale
2022
MMJ Patients
~79K
Monthly Revenue
~$48.7MM
Cultivation Licenses
1,075/No Limit (Operational/Limit)*
Retail Licenses
1,006/No Limit (Operational/Limit)*
Updated on Mar 24, 2025
CO
Colorado Market Research
Notable Players




Population
~5.8MM
Medicinal Legalization
2000
First Adult-Use Sale
2014
MMJ Patients
~69K
Monthly Revenue
~$110.3MM
Cultivation Licenses
722/No Limit (Operational/Limit)
Retail Licenses
1,023/No Limit (Operational/Limit)
Updated on Jun 13, 2024
MT
Montana Market Research
Notable Players
Population
~1.1MM
Medicinal Legalization
2004
First Adult-Use Sale
2022
MMJ Patients
No Available Data
Monthly Revenue
~$26.0MM
Cultivation Licenses
330/No Limit (Operational/Limit)
Retail Licenses
468/No Limit (Operational/Limit)
Updated on Mar 24, 2025
NV
Nevada Market Research
Notable Players




Population
~3.3MM
Medicinal Legalization
2000
First Adult-Use Sale
2017
MMJ Patients
~10.6K
Monthly Revenue
~$70.7MM
Cultivation Licenses
129/No Limit (Operational/Limit)
Retail Licenses
103/166(Operational/Limit)
Updated on Mar 24, 2025
AZ
Arizona Market Research
Notable Players




Population
~7.4MM
Medicinal Legalization
2010
First Adult-Use Sale
2021
MMJ Patients
~128K
Monthly Revenue
~$105.2MM
Cultivation Licenses
250/250 (Operational/Limit)
Retail Licenses
250/250 (Operational/Limit)
Updated on Oct 23, 2023
CA
California Market Research
Notable Players




Population
~39.0MM
Medicinal Legalization
1996
First Adult-Use Sale
2018
MMJ Patients
~467K
Monthly Revenue
~$359.2.1MM
Cultivation Licenses
5,735/No Limit (Operational/Limit)
Retail Licenses
2,387/No Limit (Operational/Limit)
Updated on Oct 23, 2023
OR
Oregon Market Research
Notable Players


Population
~4.2MM
Medicinal Legalization
1998
First Adult-Use Sale
2015
MMJ Patients
~17K
Monthly Revenue
~$80.1MM
Cultivation Licenses
1,424/No Limit (Operational/Limit)
Retail Licenses
946/No Limit (Operational/Limit)
Updated on Oct 23, 2023
WA
Washington Market Research
Notable Players

Population
~7.8MM
Medicinal Legalization
1998
First Adult-Use Sale
2014
MMJ Patients
~104K
Monthly Revenue
~$117.4MM
Cultivation Licenses
1,012/No Limit (Operational/Limit)
Retail Licenses
704/No Limit (Operational/Limit)
Updated on Oct 23, 2023
WA
Market Research
Top MSO's
Year Passed
1999
Year Passed
1999
Year Passed
1999
Year Passed
1999
Year Passed
1999
Year Passed
1999
Updated on 10/20/20
Adult & Medical Use
Legal Medical Use
Medical Use - CBD Only
Prohibited
Blinking indicates recent activity
-States that are not clickable have no meaningful activity.

NH
New Hampshire Market Research
Notable Players

Population
~1.4MM
Medicinal Legalization
2013
First Adult-Use Sale
N/A
MMJ Patients
~14K
Monthly Revenue
~$3.5MM
Cultivation Licenses
4/4 (Operational/Limit)*
Retail Licenses
7/7 (Operational/Limit)*
Updated on Mar 24, 2025
PA
Pennsylvania Market Research
Notable Players




Population
~13.0MM
Medicinal Legalization
2016
First Adult-Use Sale
N/A
MMJ Patients
~441K
Monthly Revenue
~$140.0MM
Cultivation Licenses
33/33 (Operational/Limit)
Retail Licenses
181/No Limit (Operational/Limit)*
Updated on Jun 12, 2024
FL
Florida Market Research
Notable Players



Population
~23.4MM
Medicinal Legalization
2014
First Adult-Use Sale
N/A
MMJ Patients
~899K
Monthly Revenue
~$145.5MM
Cultivation Licenses
25/27 (Operational/Limit)*
Retail Licenses
703/No Limit (Operational/Limit)*
Updated on Mar 25, 2025
GA
Georgia Market Research
Notable Players

Population
~11.2MM
Medicinal Legalization
2015
First Adult-Use Sale
N/A
MMJ Patients
~25K
Monthly Revenue
0
Cultivation Licenses
6/6 (Operational/Limit)
Retail Licenses
14/42* (Operational/Limit)
Updated on Mar 24, 2025
MS
Mississippi Market Research
Notable Players
Population
~2.9MM
Medicinal Legalization
2022
First Adult-Use Sale
N/A
MMJ Patients
51k
Monthly Revenue
~$9.2MM
Cultivation Licenses
122/No Limit (Operational/Limit)
Retail Licenses
200/No Limit (Operational/Limit)
Updated on Mar 25, 2025
AL
Alabama Market Research
Notable Players
Population
~5.2MM
Medicinal Legalization
2021
First Adult-Use Sale
N/A
MMJ Patients
N/A
Monthly Revenue
N/A
Cultivation Licenses
0/5 (Operational/Limit)
Retail Licenses
0/5 (Operational/Limit)
Updated on Mar 25, 2025
KY
Kentucky Market Research
Notable Players
Population
~4.6MM
Medicinal Legalization
2023
First Adult-Use Sale
N/A
MMJ Patients
N/A
Monthly Revenue
N/A
Cultivation Licenses
16/16 (Operational/Limit)*
Retail Licenses
48/48 (Operational/Limit)*
Updated on Mar 26, 2025
LA
Louisiana Market Research
Notable Players
Population
~4.6MM
Medicinal Legalization
2016
First Adult-Use Sale
N/A
MMJ Patients
~53K
Monthly Revenue
~$2.3MM
Cultivation Licenses
2/2 (Operational/Limit)
Retail Licenses
22/30 (Operational/ Limit)
Updated on Mar 25, 2025
AR
Arkansas Market Research
Notable Players


Population
~3.1MM
Medicinal Legalization
2016
First Adult-Use Sale
N/A
MMJ Patients
~109K
Monthly Revenue
~$24MM
Cultivation Licenses
16/16 (Operational/Limit)
Retail Licenses
38/40 (Operational/Limit)
Updated on Mar 24, 2025
IA
Iowa Market Research
Notable Players
Population
~3.2MM
Medicinal Legalization
2017
First Adult-Use Sale
N/A
MMJ Patients
~18K
Monthly Revenue
~$1.1MM
Cultivation Licenses
2/2 (Operational/Limit)
Retail Licenses
5/5 (Operational/Limit)
Updated on Mar 24, 2025
HI
Hawaii Market Research
Notable Players
Population
~1.4MM
Medicinal Legalization
2000
First Adult-Use Sale
N/A
MMJ Patients
~33K
Monthly Revenue
~$4.3MM
Cultivation Licenses
8/8 (Operational/Limit)*
Retail Licenses
23/No Limit (Operational/Limit)*
Updated on Oct 23, 2023
ND
North Dakota Market Research
Notable Players


Population
~0.8MM
Medicinal Legalization
2016
First Adult-Use Sale
N/A
MMJ Patients
~10K
Monthly Revenue
~$1.9MM
Cultivation Licenses
2/2 (Operational/Limit)
Retail Licenses
8/8 (Operational/Limit)
Updated on Mar 25, 2025
SD
South Dakota Market Research
Notable Players
Population
~0.9MM
Medicinal Legalization
2020
First Adult-Use Sale
N/A
MMJ Patients
~11k
Monthly Revenue
Not Reported
Cultivation Licenses
34/No Limit (Operational/ Limit)
Retail Licenses
65/No Limit (Operational/ Limit)
Updated on Mar 24, 2025
OK
Oklahoma Market Research
Notable Players
Population
~4.1MM
Medicinal Legalization
2018
First Adult-Use Sale
N/A
MMJ Patients
~340K
Monthly Revenue
~$60.0MM
Cultivation Licenses
2,939/No Limit (Operational/Limit)
Retail Licenses
1,747/No Limit (Operational/Limit)
Updated on Mar 25, 2025
UT
Utah Market Research
Notable Players


Population
~3.4MM
Medicinal Legalization
2018
First Adult-Use Sale
N/A
MMJ Patients
~69K
Monthly Revenue
~$12.1MM
Cultivation Licenses
8/10 (Operational/Limit)
Retail Licenses
15/15 (Operational/Limit)
Updated on Oct 23, 2023
WA
Market Research
Top MSO's
Year Passed
1999
Year Passed
1999
Year Passed
1999
Year Passed
1999
Year Passed
1999
Year Passed
1999
Updated on 10/20/20
Adult & Medical Use
Legal Medical Use
Medical Use - CBD Only
Prohibited
Blinking indicates recent activity
-States that are not clickable have no meaningful activity.

NC
North Carolina Market Research
Notable Players
Population
~11.0MM
Medicinal Legalization
First Adult-Use Sale
MMJ Patients
N/A
Monthly Revenue
N/A
Cultivation Licenses
N/A
Retail Licenses
N/A
Updated on Mar 25, 2025
SC
South Carolina Market Research
Notable Players
Population
~5.5MM
Medicinal Legalization
First Adult-Use Sale
MMJ Patients
N/A
Monthly Revenue
N/A
Cultivation Licenses
N/A
Retail Licenses
N/A
Updated on Mar 25, 2025
WI
Wisconsin Market Research
Notable Players
Population
~6.0MM
Medicinal Legalization
First Adult-Use Sale
MMJ Patients
N/A
Monthly Revenue
N/A
Cultivation Licenses
N/A
Retail Licenses
N/A
Updated on Mar 25, 2025
KS
Kansas Market Research
Notable Players
Population
~3.0MM
Medicinal Legalization
First Adult-Use Sale
MMJ Patients
N/A
Monthly Revenue
N/A
Cultivation Licenses
N/A
Retail Licenses
N/A
Updated on Mar 24, 2025
TX
Texas Market Research
Notable Players


Population
~31.3MM
Medicinal Legalization
2015
First Adult-Use Sale
MMJ Patients
~103K
Monthly Revenue
Negligible
Cultivation Licenses
3/3 (Operational/Limit)
Retail Licenses
3/3 (Operational/Limit)
Updated on Mar 25, 2025
WY
Wyoming Market Research
Notable Players
Population
~0.6MM
Medicinal Legalization
First Adult-Use Sale
MMJ Patients
N/A
Monthly Revenue
N/A
Cultivation Licenses
N/A
Retail Licenses
N/A
Updated on Mar 24, 2025
WA
Market Research
Top MSO's
Year Passed
1999
Year Passed
1999
Year Passed
1999
Year Passed
1999
Year Passed
1999
Year Passed
1999
Updated on 10/20/20
Adult & Medical Use
Legal Medical Use
Medical Use - CBD Only
Prohibited
Blinking indicates recent activity
-States that are not clickable have no meaningful activity.

No items found.
WA
Market Research
Top MSO's
Year Passed
1999
Year Passed
1999
Year Passed
1999
Year Passed
1999
Year Passed
1999
Year Passed
1999
Updated on 10/20/20
Adult & Medical Use
Legal Medical Use
Medical Use - CBD Only
Prohibited
.jpg)
Colin Campbell is part of a webinar exploring how financially struggling cannabusinesses can utilize the court system to obtain some financial breathing room.
Read more

.jpg)
As 2022 gets underway, it is time for in-state operators to get bigger, better, and stronger in Michigan. The relatively mature and robust Michigan cannabis market has seen a dramatic increase in capacity across the supply chain yet remains highly fragmented.
Read more

.jpg)
Steve Miles, Sharp's Co-Founder & CEO, was interviewed by Elliot Lane during the October 2021 Benzinga Capital Conference.
Read more

.png)
Sharp is putting on a webinar to help owner/operators in the cannabis industry better understand cannabis market consolidation and its impact on owner/operators.
Read more

connect with us
Stay up on the latest cannabis-sector updates
Copyright 2024 | Privacy & Disclosures | Website By PNW